Hyundai Bioland Co., Ltd. logo

Hyundai Bioland Co., Ltd. (052260)

Market Open
11 Aug, 04:02
KRX SM KRX SM
3,935. 00
+65
+1.6796%
111.3B Market Cap
- P/E Ratio
280% Div Yield
94,104 Volume
- Eps
3,870
Previous Close
Add Transaction
Day Range
3,750 4,025
Year Range
3,125 5,320
Want to track 052260 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

052260 trading today higher at ₩3,935, an increase of 1.6796% from yesterday's close, completing a monthly increase of 14.3895% or ₩495. Over the past 12 months, 052260 stock lost -8.912%.
052260 pays dividends to its shareholders, with the most recent payment made on Apr 09, 2026.
Hyundai Bioland Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 17, 2024.
The company's stock is traded on one exchange.

052260 Chart

People also search for

Daehan Flour Mills Co., Ltd.
11,830
0%
Gs Global Corp.
2,930
+0.5146%
Il Seung Co., Ltd.
4,050
-2.4096%
Haitai Confectionery & Foods Co., Ltd.
5,700
-0.1751%
Hankook Cosmetics Manufacturing Co., Ltd.
9,390
+4.102%

Hyundai Bioland Co., Ltd. (052260) FAQ

What is the stock price today?

The current price is ₩3,935.00.

On which exchange is it traded?

Hyundai Bioland Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 052260.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 280%.

What is its market cap?

As of today, the market cap is 111.3B.

Has Hyundai Bioland Co., Ltd. ever had a stock split?

Hyundai Bioland Co., Ltd. had 2 splits and the recent split was on May 17, 2024.

Hyundai Bioland Co., Ltd. Profile

Food Products Industry
Consumer Staples Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
17 May 2024 Last Split
- IPO Date

Overview

Hyundai Bioland Co., Ltd. is a pioneering biotechnology enterprise based in South Korea, known for its intensive focus on the research, development, and manufacturing of bioactive materials. These materials play a crucial role in a variety of sectors, including cosmetics, pharmaceuticals, and healthcare products. By harnessing the power of natural sources, Hyundai Bioland is at the forefront of introducing innovative ingredients that are not only safe but also highly effective. The company’s efforts are instrumental in the advancement of biotechnological innovations, ensuring its significant stance in both the domestic and international markets.

Products and Services

  • Functional Food Additives

    Hyundai Bioland produces a range of functional food additives designed to enhance the nutritional value and health benefits of various food products. These additives are derived from natural sources and are developed to meet the growing consumer demand for health-oriented food options. By improving the functionality of food, Hyundai Bioland contributes to the overall well-being of consumers and supports the development of healthier food alternatives.

  • Cosmetic Ingredients

    Specializing in the creation of bioactive materials, Hyundai Bioland offers a diverse portfolio of cosmetic ingredients. These ingredients are aimed at enhancing the quality and effectiveness of skincare and beauty products. Utilizing natural extracts and advanced biotechnological processes, the company provides solutions that cater to the evolving cosmetic industry's needs for sustainable and safe products. Hyundai Bioland’s cosmetic ingredients are pivotal in developing innovative formulations that offer both efficacy and luxury.

  • API (Active Pharmaceutical Ingredients)

    For the medical field, Hyundai Bioland develops and manufactures Active Pharmaceutical Ingredients (APIs) critical for the production of various drugs. These APIs are essential for creating medications that treat, prevent, or manage different health conditions. By focusing on the potency and safety of these pharmaceutical ingredients, Hyundai Bioland plays a vital role in the pharmaceutical industry, ensuring the availability of high-quality medication for global healthcare needs.

Contact Information

Address: -
Phone: -